XTRA:DRW3Medical Equipment
Is Drägerwerk KGaA (XTRA:DRW3) Undervalued Following Strong Q2 2026 Earnings?
Drägerwerk KGaA (XTRA:DRW3) drew fresh attention after reporting second quarter 2026 earnings, with sales of €847.31 million and net income of €29.52 million compared with the prior year’s figures.
See our latest analysis for Drägerwerk KGaA.
The strong second quarter numbers arrived after a period of sharp share price gains for Drägerwerk KGaA, with the stock closing at €109.4 and showing a 30.55% 1 month share price return and 59.94% year to date share price return, alongside a 165.19% 3...